-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Hold on Fate Therapeuticsto Hold

Benzinga·05/14/2025 11:31:55
Listen to the news
Needham analyst Gil Blum reiterates Fate Therapeutics (NASDAQ:FATE) from Hold to Hold.